In this program expert panelists will discuss these issues using trial data, clinical experience and case examples to demonstrate the benefits of moving to TAVR as the primary treatment option for low-risk AS patients.

In this program participants will learn about valve durability, treating bicuspid patients, and advanced valve-in-valve concepts. Expert panelists also discuss recent clinical trial data.

This interactive program, led by expert faculty members, covers TMVR clinical trial design, appropriate patient selection and screening, and optimal care.

This webcast discussion will move beyond high-risk patients and explore the new boundaries of transcatheter therapy. Participants will learn from discussions about considerations for low-risk patient populations, treatment decision making, and recent clinical trial data.

This program will provide comprehensive overview of recent clinical trials and practical implications, case-based review of MR treatment options, and discussion of approaches for selecting appropriate surgical or transcatheter MR therapies.

This webcast will help interventional cardiologists and other members of the cardiac care team ensure that ASCVD patients receive optimal lipid-lowering therapy to reduce the risk of recurrent events.